| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |